{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:39:29Z","timestamp":1785753569381,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,30]]},"DOI":"10.7759\/cureus.28608","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T04:33:55Z","timestamp":1661920435000},"source":"Crossref","is-referenced-by-count":3,"title":["Efficacy of Direct Renin Inhibitors in Slowing Down the Progression of Diabetic Kidney Disease: A Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Hanieh","family":"Akbariromani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushna","family":"Haseeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumreen","family":"Nazly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata","family":"Anirudh Chunchu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandesh","family":"Dhakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Anne","family":"Claudine Avena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelum","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.12.004","article-title":"US Renal Data System 2016 Annual Data Report: epidemiology of kidney disease in the United States","volume":"69","author":"Saran R","year":"2017","unstructured":"Saran R, Robinson B, Abbott KC, et al.. US Renal Data System 2016 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2017, 69:A7-8. 10.1053\/j.ajkd.2016.12.004","journal-title":"Am J Kidney Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfv151","article-title":"Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus","volume":"9","author":"Kramer A","year":"2016","unstructured":"Kramer A, Pippias M, Stel VS, et al.. Renal replacement therapy in Europe: a summary of the 2013 ERA-EDTA Registry Annual Report with a focus on diabetes mellitus. Clin Kidney J. 2016, 9:457-69. 10.1093\/ckj\/sfv151","journal-title":"Clin Kidney J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.861","article-title":"Temporal trends in the prevalence of diabetic kidney disease in the United States","volume":"305","author":"de Boer IH","year":"2011","unstructured":"de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011, 305:2532-9. 10.1001\/jama.2011.861","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/1056-8727(95)80036-E","article-title":"Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patients","volume":"9","author":"Mogensen CE","year":"1995","unstructured":"Mogensen CE. Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patients. J Diabetes Complicat. 1995, 9:337-49. 10.1016\/1056-8727(95)80036-E","journal-title":"J Diabetes Complicat"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"de Zeeuw D","year":"2004","unstructured":"de Zeeuw D, Remuzzi G, Parving HH, et al.. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004, 110:921-7. 10.1161\/01.CIR.0000139860.33974.28","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006257","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease","author":"Strippoli GF","year":"2006","unstructured":"Strippoli GF, Bonifati C, Craig ME, Navaneethan SD, Craig JC. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease. Cochrane Database Syst Rev. 2006, CD006257. 10.1002\/14651858.CD006257","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1542-0","article-title":"Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate","volume":"47","author":"Schjoedt KJ","year":"2004","unstructured":"Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia. 2004, 47:1936-9. 10.1007\/s00125-004-1542-0","journal-title":"Diabetologia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.767202","article-title":"Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans","volume":"117","author":"Fisher ND","year":"2008","unstructured":"Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Circulation. 2008, 117:3199-205. 10.1161\/CIRCULATIONAHA.108.767202","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708379","article-title":"Aliskiren combined with losartan in type 2 diabetes and nephropathy","volume":"358","author":"Parving HH","year":"2008","unstructured":"Parving HH, Persson F, Lewis JB, Lewis EJ, Hollenberg NK. Aliskiren combined with losartan in type 2 diabetes and nephropathy. N Engl J Med. 2008, 358:2433-46. 10.1056\/NEJMoa0708379","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner BM","year":"2001","unstructured":"Brenner BM, Cooper ME, de Zeeuw D, et al.. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001, 345:861-9. 10.1056\/NEJMoa011161","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07720618","article-title":"Efficacy and safety of imarikiren in patients with type 2 diabetes and microalbuminuria: a randomized, controlled trial","volume":"14","author":"Ito S","year":"2019","unstructured":"Ito S, Kagawa T, Saiki T, Shimizu K, Kuroda S, Sano Y, Umeda Y. Efficacy and safety of imarikiren in patients with type 2 diabetes and microalbuminuria: a randomized, controlled trial. Clin J Am Soc Nephrol. 2019, 14:354-63. 10.2215\/CJN.07720618","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving HH","year":"2012","unstructured":"Parving HH, Brenner BM, McMurray JJ, et al.. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012, 367:2204-13. 10.1056\/NEJMoa1208799","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164936","article-title":"Comparative effects of direct renin inhibitor and angiotensin receptor blocker on albuminuria in hypertensive patients with type 2 diabetes. A randomized controlled trial","volume":"11","author":"Uzu T","year":"2016","unstructured":"Uzu T, Araki SI, Kashiwagi A, et al.. Comparative effects of direct renin inhibitor and angiotensin receptor blocker on albuminuria in hypertensive patients with type 2 diabetes. A randomized controlled trial. PLoS One. 2016, 11:e0164936. 10.1371\/journal.pone.0164936","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya T","year":"2009","unstructured":"Ninomiya T, Perkovic V, de Galan BE, et al.. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009, 20:1813-21. 10.1681\/ASN.2008121270","journal-title":"J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.490","article-title":"Microalbuminuria: target for renoprotective therapy PRO","volume":"86","author":"Roscioni SS","year":"2014","unstructured":"Roscioni SS, Lambers Heerspink HJ, de Zeeuw D. Microalbuminuria: target for renoprotective therapy PRO. Kidney Int. 2014, 86:40-9. 10.1038\/ki.2013.490","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11511114","article-title":"Albuminuria is an appropriate therapeutic target in patients with CKD: the Pro view","volume":"10","author":"Lambers Heerspink HJ","year":"2015","unstructured":"Lambers Heerspink HJ, Gansevoort RT. Albuminuria is an appropriate therapeutic target in patients with CKD: the Pro view. Clin J Am Soc Nephrol. 2015, 10:1079-88. 10.2215\/CJN.11511114","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/hjh.0b013e32834069bd","article-title":"Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial","volume":"29","author":"Ruggenenti P","year":"2011","unstructured":"Ruggenenti P, Fassi A, Ilieva AP, et al.. Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial. J Hypertens. 2011, 29:207-16. 10.1097\/hjh.0b013e32834069bd","journal-title":"J Hypertens"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1922-6","article-title":"Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial","volume":"54","author":"Miao Y","year":"2011","unstructured":"Miao Y, Dobre D, Heerspink HJ, et al.. Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. Diabetologia. 2011, 54:44-50. 10.1007\/s00125-010-1922-6","journal-title":"Diabetologia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1646","article-title":"Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes","volume":"56","author":"Araki S","year":"2007","unstructured":"Araki S, Haneda M, Koya D, et al.. Reduction in microalbuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes. Diabetes. 2007, 56:1727-30. 10.2337\/db06-1646","journal-title":"Diabetes"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e42","article-title":"The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis","volume":"344","author":"Harel Z","year":"2012","unstructured":"Harel Z, Gilbert C, Wald R, et al.. The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis. BMJ. 2012, 344:e42. 10.1136\/bmj.e42","journal-title":"BMJ"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer MA","year":"2003","unstructured":"Pfeffer MA, McMurray JJ, Velazquez EJ, et al.. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med. 2003, 349:1893-906. 10.1056\/NEJMoa032292","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf S","year":"2008","unstructured":"Yusuf S, Teo KK, Pogue J, et al.. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008, 358:1547-59. 10.1056\/NEJMoa0801317","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/112124-efficacy-of-direct-renin-inhibitors-in-slowing-down-the-progression-of-diabetic-kidney-disease-a-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:35Z","timestamp":1707507635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/112124-efficacy-of-direct-renin-inhibitors-in-slowing-down-the-progression-of-diabetic-kidney-disease-a-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.28608","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,30]]}}}